← All trials
NCT01690637
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2012
- Primary completion
- Nov 1, 2013
- Completion date
- Nov 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 721
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Centers for Disease Control and Prevention (CDC)Lead sponsor
- Universidad del Valle de GuatemalaOverall official - principal investigator
- Hospital Nacional San Juan de Dios de Santa Ana, El SalvadorCollaborator
- Hospital Nacional San Juan de Dios de San Miguel, El SalvadorCollaborator
- Hospital Del Nino, PanamaCollaborator
- Hospital Jose Domingo de Obaldia, PanamaCollaborator
- Universidad del Valle de GuatemalaCollaborator
- Centers for Disease Control and Prevention (CDC)Overall official - principal investigator
- Centers for Disease Control and Prevention (CDC)Reponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.